TALACOTUZUMAB
UNII X8JR0I7JE1

Substance Identification & Data

This profile provides standardized clinical and technical data for Talacotuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X8JR0I7JE1.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1826831-79-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

X8JR0I7JE1

CAS Registry Number

1826831-79-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TALACOTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C102784

National Cancer Institute reference terminology for clinical and research data.

INN ID

10508

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Talacotuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TALACOTUZUMAB

Common Names & Synonyms

ANTI-IL-3 RECEPTOR ALPHA MONOCLONAL ANTIBODY CSL362

IMMUNOGLOBULIN G1-2-KAPPA, ANTI-(HOMO SAPIENS IL3RA (INTERLEUKIN 3 RECEPTOR SUBUNIT ALPHA, INTERLEUKIN 3 RECEPTOR ALPHA (LOW AFFINITY), CD123)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1-2 HEAVY CHAIN (1-450) (HUMANIZED VH (HOMO SAPIENS IGHV5-51*01 (82.70%) -(IGHD) -IGHJ3*01) (8.8.13) (1-120) -HOMO SAPIENS IGHG1*01 (CH1 G1M17, K120 (217) (121-218) -HINGE (219-233) -CH2 1.6-1.1 (234-239)) (121-239) -HOMO SAPIENS IGHG2*01 (CH2 1-125, S3>D (242), G2M.. V45.1 (285), G110>A (330), I117>E (335) (240-343) -CH3 NG1M1 E12 (359), M14 (361) (344-448), CHS (449-450)) (240-450)), (223-220')-DISULFIDE WITH KAPPA LIGHT CHAIN (1-220) (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV4-1*01 (90.10%) -IGKJ2*01) (12.3.9) (1'-113') -HOMO SAPIENS IGKC*01, KM3 A45.1 (159), V101 (197) (114'-220'))DIMER (229-229'':232-232'')-BISDISULFIDE

TALACOTUZUMAB [INN]

TALACOTUZUMAB [WHO-DD]